Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 2:4:81.
doi: 10.3389/fimmu.2013.00081. eCollection 2013.

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants

Tobias R Kollmann  1
Affiliations

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants

Tobias R Kollmann. Front Immunol. .

Abstract

The success of the World Health Organization recommended "Expanded Program of Immunization" (EPI) and similar regional or national programs has been astounding. However, infectious threats currently not covered by these programs continue to infect millions of infants around the world. Furthermore, many infants do not receive existing vaccines either on time or for the required number of doses to provide optimal protection. Nor do all infants around the world develop the same protective immune response to the same vaccine. As a result approximately three million infants die every year from vaccine preventable infections. To tackle these issues, new vaccines need to be developed as well as existing ones made easier to administer. This requires identification of age-optimized vaccine schedules and formulations. In order to be most effective this approach will need to take population-based differences in response to vaccines and adjuvants into account. This review summarizes what is currently known about differences between populations around the world in the innate immune response to existing as well as new and promising vaccine adjuvants.

Keywords: adjuvants; environment; genetics; innate immunity; vaccine.

PubMed Disclaimer

References

    1. Aaby P., Whittle H., Stabell Benn C. (2012). Vaccine programmes must consider their effect on general resistance. BMJ 344, e3769.10.1136/bmj.e3769 - DOI - PubMed
    1. Abebe F. (2012). Is interferon-gamma the right marker for Bacille Calmette-Guerin-induced immune protection? Clin. Exp. Immunol. 169, 213–21910.1111/j.1365-2249.2012.04614.x - DOI - PMC - PubMed
    1. Adegnika A. A., Kohler C., Agnandji S. T., Chai S. K., Labuda L., Breitling L. P., et al. (2008). Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood. J. Infect. Dis. 198, 928–93610.1086/591057 - DOI - PubMed
    1. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R. T., et al. (2002). Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8, 1–710.1038/nm0102-1 - DOI - PubMed
    1. Alm J. S., Swartz J., Bjorksten B., Engstrand L., Engstrom J. I., Lilja G., et al. (2002). An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr. Allergy Immunol. 13, 402–41110.1034/j.1399-3038.2002.01062.x - DOI - PubMed